CHELSEA HARVEY: Open Payments
NPI 1700422391 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,130 in 40 payments from 12 companies in 2025. Trend: 2023 $572 · 2024 $1,164 · 2025 $1,130
Food & beverage: $1,130
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $224 |
| E.R. Squibb & Sons, L.L.C. | 3 | $169 |
| Alnylam Pharmaceuticals Inc. | 1 | $143 |
| SCPHARMACEUTICALS INC. | 4 | $130 |
| BridgeBio Pharma, Inc. | 1 | $94 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| PFIZER INC. | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Novo Nordisk Inc | 2 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
Products named: REPATHA, AMVUTTRA, FUROSCIX, Attruby, VYNDAQEL, LEQVIO, Wegovy, JARDIANCE.
Industry payments across PA — which companies pay providers there.
